Clinical Trials at Stanford University Medical Center
As of June 2026, 41 paid clinical trials are recruiting at Stanford University Medical Center, located at 300 PASTEUR DRIVE, ROOM A343 DEPARTMENT OF NEUROLOGY, STANFORD, CA 94305-5235, phone (650) 725-6688 in Stanford, California. Active studies at this site cover conditions such as Autism Spectrum Disorder, Autism and Atrial Fibrillation. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
41 clinical trials at Stanford University Medical Center
·Clear filters·↓ Download CSVGATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
StrokeNet Thrombectomy Endovascular Platform
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
CARES (Comprehensive Analgesic, Recovery, and Education Support) for Surgery Trial
Long-term Result of DTPA (Diethylenetriamine Pentaacetate) Chelation for Gadolinium Deposition Disease
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
Janus Kinase Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
PARTNER 3 Trial - Aortic Valve-in-Valve
CAR-T Long Term Follow Up (LTFU) Study
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
Safety and Durability of Sirolimus for Treatment of LAM
A Long-term Extension Study of PCI-32765 (Ibrutinib)
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Longitudinal Study of Urea Cycle Disorders
TrialNet Pathway to Prevention of T1D
Fabry Disease Registry & Pregnancy Sub-registry
About research studies in Stanford
Stanford has approximately 448 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Common conditions studied in Stanford
- Autism Spectrum Disorder (17 active studies). Recruiting Autism Spectrum Disorder studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Autism (13 active studies). Recruiting Autism studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Atrial Fibrillation (7 active studies). Atrial fibrillation studies investigate next-generation anticoagulants, ablation technologies, and left atrial appendage closure devices.
- Cancer (7 active studies). Recruiting Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Heart Failure (7 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Breast Cancer (6 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
Leading research sponsors in Stanford
- Stanford University
- AstraZeneca
- Eli Lilly and Company
- W.L.Gore & Associates
- Duke University
Local regulations and guidelines
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Stanford. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Stanford
Hipa.ai aggregates every recruiting study in Stanford from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Stanford?
There are approximately 448 recruiting clinical trials in Stanford, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Stanford pay participants?
Most recruiting trials in Stanford compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Stanford?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Stanford?
The most common conditions under active study in Stanford include Autism Spectrum Disorder (17), Autism (13), Atrial Fibrillation (7), Cancer (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Stanford?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Stanford on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Stanford?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Stanford?
Recruiting research sites in Stanford include Stanford University, Stanford University School of Medicine, Stanford University Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Stanford right now?
The largest active categories in Stanford are Cancer & tumors (103), Cardiovascular (40), Neurology & pain (36). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Stanford University Medical Center?
Stanford University Medical Center is located at 300 PASTEUR DRIVE, ROOM A343 DEPARTMENT OF NEUROLOGY, STANFORD, CA 94305-5235. Use the Google Maps link in the intro above to get directions.
How do I contact Stanford University Medical Center?
You can reach Stanford University Medical Center by phone at (650) 725-6688. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.